KLRK1 and colorectal carcinoma: Furthermore, no significant differences were observed in expression levels of NK activating (NKG2D, NKG2C) and NK inhibiting (NKG2A, KIR2D) receptors between healthy controls and CRC patients (Figure S1 in Supplementary Material).